Navigation Links
ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
Date:9/16/2010

IRVINE, Calif., Sept. 16 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced that it has initiated a Phase 3 clinical program of ISTA's proprietary formulation of REMURA™ (bromfenac ophthalmic solution for dry eye) for alleviating the signs and symptoms of dry eye disease. The Phase 3 efficacy studies are being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

"We are pleased by the initiation of our pivotal REMURA dry eye efficacy program. Further, reaching agreement with the FDA on the SPA for REMURA efficacy studies provides additional clarity regarding the path to approval, which will help us to bring a safe and effective treatment to patients suffering from dry eye," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA.   "Dry eye is a large and growing market, with 2010 worldwide prescription sales expected to be about $600 million.  Dry eye also is an underserved market, as patients suffering from chronic dry eye syndrome have few quality therapy options.  We are very excited by the potential of REMURA as a new treatment modality for dry eye patients."

At this time, ISTA plans to assess the safety and efficacy of REMURA in alleviating the signs and symptoms of dry eye disease by conducting four randomized, double-masked, placebo-controlled Phase 3 studies. The recently initiated Phase 3 studies will evaluate the efficacy and safety of bromfenac in two simultaneous studies operating under a common protocol in approximately 1000 patients with mild or moderate dry eye disease. The multi-center trials will be conducted at more than 30 sites in the U.S. Two concentrations of bromfenac (both lower than the currently marketed Xibrom (bromfenac ophthalmic solution)® 0.09%), will be dosed in addition to placebo. Patients will be ra
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
4. Access Pharmaceuticals Launches MuGard Product Website
5. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
6. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
7. ARCADIS Jane Staveley to Moderate Congressional Briefing on Pharmaceuticals in Drinking Water
8. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
9. Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...   Sigma-Aldrich Corporation (NASDAQ: SIAL ) a ... a $50,000 product donation to the Reproducibility Project: ... findings from recent high-impact papers in the field of ... online research marketplace Science Exchange , the non-profit ... journal eLife. The goal of the project ...
(Date:5/6/2015)... May 6, 2015 AbbVie (NYSE: ABBV ... Lynch 2015 Health Care Conference on Wednesday, May 13, ... executive officer, will participate in a question and answer ... live audio webcast of the presentation will be accessible ... .  An archived edition of the session will be ...
(Date:5/6/2015)... Pharmaceuticals, Inc. (Nasdaq: JNP ) ("Juniper" or the ... ended March 31, 2015. First quarter financial highlights include: ... 19% as compared to $7.0 million in the first ... year-over-year, enabled by the return of normalized CRINONE ® ... fourth quarter of 2014; , Service revenues grew ...
Breaking Medicine Technology:Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... Mass. and SYDNEY, Nov. 4 HeartWare International, Inc. ... and provider of less invasive, miniaturized circulatory support technologies ... a significant increase in revenues to $7.5 million for ... to approximately $3.0 million in revenues in the second ...
... 4 Sanford Wittels & Heisler, LLP, along with ... medical device company specializing in cardiac surgical ablation systems, ... of Justice (DOJ) in a qui tam case filed ... five-year period. , Sanford Wittels & Heisler and Grant ...
Cached Medicine Technology:HeartWare International Reports Third Quarter Revenues of $7.5 Million 2HeartWare International Reports Third Quarter Revenues of $7.5 Million 3HeartWare International Reports Third Quarter Revenues of $7.5 Million 4HeartWare International Reports Third Quarter Revenues of $7.5 Million 5HeartWare International Reports Third Quarter Revenues of $7.5 Million 6HeartWare International Reports Third Quarter Revenues of $7.5 Million 7Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2
(Date:5/6/2015)... 06, 2015 The Center for Innovative ... has invested in e-Kare, Inc. of Fairfax, VA, a ... monitoring of chronic wounds. , Chronic wounds include pressure, ... wounds that affect over 6.5 million U.S. patients, costing ... spin-off enterprise from the Children’s National Medical Center (CNMC), ...
(Date:5/6/2015)... Aliso Viejo, CA (PRWEB) May 06, 2015 ... of unique and fun self-animating generators for Final ... users to add stylistic titles to a Final Cut ... unique environments, adding professional quality openers to any shot ... for any skill level in mind, saving users time ...
(Date:5/6/2015)... 06, 2015 Healthcare marketing agency ... a silver award in the 2015 Aster Awards for ... and Ellis Medicine’s maternity campaign, respectively. The Aster Awards ... organizations and marketing agencies. , The branding campaign ... line — other/misc. category and hospital 150-200 bed group. ...
(Date:5/6/2015)... 2015 The SGNY Group LLC (SGNY), ... announced today that it was named a Platinum winner ... video produced on behalf of Intarcia Therapeutics. SGNY ... motion graphics. , The competition sponsored by the Association ... entries from 22 countries. The competition is an ...
(Date:5/6/2015)... 2015 The beverage industry has grocery ... Miracles organic tea and superfruit fusions stands out among ... sweetened with agave, these delicious juice blends are making ... healthier ways to hydrate. , In collaboration with National ... to raise a bottle of Lemongrass Tea and Ginseng, ...
Breaking Medicine News(10 mins):Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3Health News:Pixel Film Studios announces the release of Protrailer Cartoon Volume 2 for Final Cut Pro X. 2Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Say Cheers to National Beverage Day with Little Miracles 2
... The ,Help is Here Express, bus tour will ... 13 -- April 17 at various cities in order ... programs that provide prescription medicines for free or nearly ... percent, the Partnership for Prescription Assistance (PPA) is ready ...
... a new procedure for regenerating damaged articular cartilage in ... Rush is the only center in Illinois participating ... procedure, called the Cartilage Autograft Implantation System (CAIS), involves ... the knee, breaking it into tiny fragments to enable ...
... a neurobiological condition which is often responsive to Applied ... fail to provide this medically necessary service to their ... as the Mental Health Parity Act, has been on ... obliges private health insurance companies to offer treatment services ...
... of residue, study finds , , THURSDAY, April 9 (HealthDay News) ... do not smoke have elevated levels of the residue of ... , And that suggests that nonsmokers in the city -- ... are not adequately protected from cigarette smoke, it says. , ...
... FREE TO THE PUBLICPanel Discussion To Follow With Local ... A free screening of HBO Documentary Films, THE ... at The Neurosciences Institute (10640 John Jay Hopkins Dr.) ... 6:00pm. Following the film, Hal Clement, anchor-reporter with 10News ...
... two-decade surge of legalized gambling is chipping away at ... accounts of bettors, a comprehensive new collection of research ... money from consumer products and services, weakening the economic ... latest volume in the three-part United States International Gambling ...
Cached Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 4Health News:Study assesses new surgical procedure for regenerating cartilage in damaged knee joints 2Health News:Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments 2Health News:Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments 3Health News:Secondhand Smoke Affecting Millions of New Yorkers 2Health News:HBO, UCSD Shiley-Marcos Alzheimer's Disease Research Center, The Alzheimer's Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMER'S PROJECT: 'MOMENTUM IN SCIENCE' 2Health News:Gambling threatens national security, new book warns 2
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: